Seed Health’s New CEO Reveals Bold Plans for the Future of Microbiome Wellness

In a fast-evolving health-tech landscape where gut health is no longer just a buzzword but a billion-dollar industry, Seed Health has emerged as a leader in microbiome innovation. And now, with Cathrin Bowtell stepping in as the new CEO, the company is signaling a fresh chapter of growth — and gutsy ambition.

Taking the reins in April 2025, Bowtell brings with her two years of internal leadership experience at Seed, first as Chief Commercial Officer and then as President. Her appointment marks a strategic evolution at a time when the microbiome brand is expanding into new consumer health territories — most notably with the launch of Sprouts, Seed’s latest line aimed at next-generation probiotic solutions.

“This is more than a job for me — it’s a mission,” Bowtell said in an exclusive interview. “Our microbiome plays a central role in every aspect of health, from digestion and immunity to skin, mood, and even aging. Seed’s role is to translate this science into real-world impact.”

The Sprouts launch is a pivotal move, designed to bring cutting-edge microbiome support to younger audiences and first-time probiotic users. Unlike traditional capsules or supplements, Sprouts take a food-first approach — one that integrates seamlessly into daily routines without compromising efficacy.

“We wanted to reimagine what entry-level microbiome support could look like,” Bowtell explained. “Sprouts is our answer — approachable, innovative, and science-backed, just like everything we do.”

Bowtell’s rise to CEO comes at a time of massive transformation within the wellness sector, where consumers are becoming increasingly educated and demand transparency, traceability, and proven efficacy. Her experience building Seed’s commercial footprint gives her unique insight into what today’s wellness-minded consumer really wants — and what the future demands.

Seed’s mission isn’t limited to selling products. It’s deeply rooted in advancing scientific research and education around the microbiome. Under Bowtell’s leadership, the company is expected to deepen its commitment to partnerships with academic institutions and launch more data-backed clinical initiatives.

“Our approach has always been science-first,” she emphasized. “But science has to meet people where they are. That’s what makes this work so exciting — we get to bring extraordinary breakthroughs to everyday life.”

As Seed sets its sights on international expansion, a broader range of targeted formulations, and more sustainability-forward initiatives, Bowtell’s leadership signals an era where purpose and performance go hand in hand.

In an industry often cluttered by hype and half-truths, Bowtell’s strategy is refreshingly clear: combine scientific rigor with unmatched consumer experience.

“People are smarter than ever about their health,” she said. “And our job is to stay ahead — with honesty, innovation, and integrity.”